Stockhead on MSN
Health Check: Imricor shares soar on the heart device play’s second FDA clearance this month
Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...
A new microfluidic device promises to revolutionize kidney disease screening by enabling rapid, accurate, and low-cost testing of creatinine levels in urine. Creatinine is a key biomarker used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results